Monday, September 13, 2021 2:50:44 PM
What they are actually saying is that because the trial has taken longer to enroll, they can enroll less and have the same power.
As you know, power is primarily a factor of events. So if the accrual is slower you will have more events at time of full recruitment because more early patients have had time to event. Thus, same number of events with less enrolled.
I am not making a prediction on the NSCLC trial. But that data (expected end of 2022) is the key for them. Their "home run"
EDIT: And if they get that home run, I doubt they will wait around for 3+ years to show it
Recent NWBO News
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
